Loading clinical trials...
Loading clinical trials...
Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are characterized by extraintestinal manifestations in approximately 30% of cases. Only 3% of these manifestations ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre of Postgraduate Medical Education
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT05421455 · Crohn Disease
NCT06226883 · Inflammatory Bowel Diseases, Crohn's Disease
NCT05986136 · Inflammatory Bowel Diseases
NCT07245394 · Inflammatory Bowel Disease (IBD), Crohn Disease (CD), and more
Szpital Bielański im. Jerzego Popiełuszki
Warsaw, Masovian Voivodeship
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions